{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:32:54Z","timestamp":1782977574989,"version":"3.54.5"},"reference-count":26,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1134\/s0006297924602739","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:05:41Z","timestamp":1741349141000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of LRRK2 Inhibition on the Activity of Glucocerebrosidase in Patient-Specific Cells from Patients with Gaucher Disease"],"prefix":"10.1134","volume":"90","author":[{"given":"Tatiana S.","family":"Usenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina S.","family":"Basharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia I.","family":"Bezrukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim A.","family":"Bezrukikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina V.","family":"Baydakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina Yu.","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofya N.","family":"Pchelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"2802_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020441","volume":"18","author":"J. \u00d4. Stirnemann","year":"2017","unstructured":"Stirnemann, J. \u00d4., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., Rose, C., Billette de Villemeur, T., and Berger, M. (2017) A review of Gaucher disease pathophysiology, clinical presentation and treatments, Int.\u00a0J. Mol. Sci., 18, 441, \nhttps:\/\/doi.org\/10.3390\/ijms18020441.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2802_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/17512433.2018.1549486","volume":"11","author":"P. Gupta","year":"2018","unstructured":"Gupta, P., and Pastores, G. (2018) Pharmacological treatment of pediatric Gaucher disease, Expert Rev. Clin. Pharmacol., 11, 1183-1194, \nhttps:\/\/doi.org\/10.1080\/17512433.2018.1549486.","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"2802_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bcmd.2010.08.012","volume":"46","author":"N. Gupta","year":"2011","unstructured":"Gupta, N., Oppenheim, I. M., Kauvar, E. F., Tayebi, N., and Sidransky, E. (2011) Type\u00a02 Gaucher disease: phenotypic variation and genotypic heterogeneity, Blood Cells Mol. Dis., 46, 75-84, \nhttps:\/\/doi.org\/10.1016\/j.bcmd.2010.08.012.","journal-title":"Blood Cells Mol. Dis."},{"key":"2802_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mds.29314","volume":"38","author":"S. C. Parlar","year":"2023","unstructured":"Parlar, S. C., Grenn, F. P., Kim, J. J., Baluwendraat, C., and Gan-Or, Z. (2023) Classification of GBA1 variants in Parkinson\u2019s disease: the GBA1-PD browser, Mov. Disord., 38, 489-495, \nhttps:\/\/doi.org\/10.1002\/mds.29314.","journal-title":"Mov. Disord."},{"key":"2802_CR5","doi-asserted-by":"publisher","first-page":"267.e7","DOI":"10.1016\/j.neurobiolaging.2018.06.027","volume":"267","author":"A. K. Emelyanov","year":"2018","unstructured":"Emelyanov, A. K., Usenko, T. S., Tesson, C., Senkevich, K. A., Nikolaev, M. A., Miliukhina, I. V., Kopytova, A. E., Timofeeva, A. A., Yakimovsky, A. F., Lesage, S., Brice, A., and Pchelina, S. N. (2018) Mutation analysis of Parkinson\u2019s disease genes in a Russian data set, Neurobiol. Aging, 267, 267.e7-267.e10, \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.027.","journal-title":"Neurobiol. Aging"},{"key":"2802_CR6","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/mds.27393","volume":"33","author":"S. Pchelina","year":"2018","unstructured":"Pchelina, S., Baydakova, G., Nikolaev, M., Senkevich, K., Emelyanov, A., Kopytova, A., Miliukhina, I., Yakimovskii, A., Timofeeva, A., Berkovich, O., Fedotova, E., Illarioshkin, S., and Zakharova, E. (2018) Blood lysosphingolipids accumulation in patients with Parkinson\u2019s disease with glucocerebrosidase\u00a01 mutations, Mov. Disord., 33, 1325-1330, \nhttps:\/\/doi.org\/10.1002\/mds.27393.","journal-title":"Mov. Disord."},{"key":"2802_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/mds.29132","volume":"37","author":"A. E. Kopytova","year":"2022","unstructured":"Kopytova, A. E., Usenko, T. S., Baydakova, G. V., Nikolaev, M. A., Senkevich, K. A., Izyumchenko, A. D., Tyurin, A. A., Miliukhina, I. V., Emelyanov, A. K., Zakharova, E. Y., and Pchelina, S. N. (2022) Could blood hexosylsphingosine be a marker for Parkinson\u2019s disease linked with GBA1 mutations? Mov. Disord., 37, 1779-1781, \nhttps:\/\/doi.org\/10.1002\/mds.29132.","journal-title":"Mov. Disord."},{"key":"2802_CR8","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"R. N. Alcalay","year":"2015","unstructured":"Alcalay, R. N., Levy, O. A., Waters, C. C., Fahn, S., Ford, B., Kuo, S. H., Mazzoni, P., Pauciulo, M. W., Nichols, W. C., Gan-Or, Z., Rouleau, G. A., Chung, W. K., Wolf, P., Oliva, P., Keutzer, J., Marder, K., and Zhang, X. (2015) Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations, Brain, 138, 2648-2658, \nhttps:\/\/doi.org\/10.1093\/brain\/awv179.","journal-title":"Brain"},{"key":"2802_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/cclm-2016-0340","volume":"55","author":"G. Polo","year":"2017","unstructured":"Polo, G., Burlina, A. P., Kolamunnage, T. B., Zampieri, M., Dionisi-Vici, C., Strisciuglio, P., Zaninotto, M., Plebani, M., and Burlina, A.\u00a0B. (2017) Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS, Clin. Chem. Lab. Med., 55, 403-414, \nhttps:\/\/doi.org\/10.1515\/cclm-2016-0340.","journal-title":"Clin. Chem. Lab. Med."},{"key":"2802_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2021.02.003","volume":"84","author":"A. E. Kopytova","year":"2011","unstructured":"Kopytova, A. E., Rychkov, G. N., Nikolaev, M. A., Baydakova, G. V., Cheblokov, A. A., Senkevich, K. A., Bogdanova, D. A., Bolshakova, O. I., Miliukhina, I. V., Bezrukikh, V. A., Salogub, G. N., Sarantseva, S. V., Usenko, T. C., Zakharova, E. Y., Emelyanov, A. K., and Pchelina, S. N. (2011) Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and parkinsonism, Parkinsonism Relat. Disord., 84, 112-121, \nhttps:\/\/doi.org\/10.1016\/j.parkreldis.2021.02.003.","journal-title":"Parkinsonism Relat. Disord."},{"key":"2802_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/ijms24109105","volume":"24","author":"A. E. Kopytova","year":"2023","unstructured":"Kopytova, A. E., Rychkov, G. N., Cheblokov, A. A., Grigor\u2019eva, E. V., Nikolaev, M. A., Yarkova, E. S., Sorogina, D. A., Ibatullin, F. M., Baydakova, G. V., Izyumchenko, A. D., Bogdanova, D. A., Boitsov, V. M., Rybakov, A. V., Miliukhina, I. V., Bezrukikh, V. A., Salogub, G. N., Zakharova, E. Y., Pchelina, S. N., and Emelyanov, A. K. (2023) Potential binding sites of pharmacological chaperone NCGC00241607 on mutant \u03b2-glucocerebrosidase and its efficacy on patient-derived cell cultures in Gaucher and Parkinson\u2019s disease, Int.\u00a0J. Mol. Sci., 24, 91-105, \nhttps:\/\/doi.org\/10.3390\/ijms24109105.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2802_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008659","volume":"6","author":"E. Aflaki","year":"2014","unstructured":"Aflaki, E., Stubblefield, B. K., Maniwang, E., Lopez, G., Moaven, N., Goldin, E., Marugan, J., Patnaik, S., Dutra, A., Southall, N., Zheng, W., Tayebi, N., and Sidransky, E. (2014) Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs, Sci. Transl. Med., 6, 240ra73, \nhttps:\/\/doi.org\/10.1126\/scitranslmed.3008659.","journal-title":"Sci. Transl. Med."},{"key":"2802_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddx410","volume":"27","author":"Z. Liu","year":"2018","unstructured":"Liu, Z., Bryant, N., Kumaran, R., Beilina, A., Abeliovich, A., Cookson, M.\u00a0R., and West, A.\u00a0B. (2018) LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-Bound Rab7L1 to promote recruitment to the trans-Golgi network, Hum. Mol. Genet., 27, 385-395, \nhttps:\/\/doi.org\/10.1093\/hmg\/ddx410.","journal-title":"Hum. Mol. Genet."},{"key":"2802_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79771","volume":"11","author":"E. G. Vides","year":"2022","unstructured":"Vides, E. G., Adhikari, A., Chiang, C. Y., Lis, P., Purlyte, E., Limouse, C., Shumate, J. L., Sp\u00ednola-Lasso, E., Dhekne, H. S., Alessi, D.\u00a0R., and Pfeffer, S. R. (2022) A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation, Elife, 11, e79771, \nhttps:\/\/doi.org\/10.7554\/eLife.79771.","journal-title":"Elife"},{"key":"2802_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00544-7","volume":"9","author":"J. M. Taymans","year":"2023","unstructured":"Taymans, J. M., Fell, M., Greenamyre, T., Hirst, W. D., Mamais, A., Padmanabhan, S., Peter, I., Rideout, H., and Thaler, A. (2023) Perspective on the current state of the LRRK2 field, NPJ Parkinsons Dis., 9, 104, \nhttps:\/\/doi.org\/10.1038\/s41531-023-00544-7.","journal-title":"NPJ Parkinsons Dis."},{"key":"2802_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13413-w","volume":"10","author":"D. Ysselstein","year":"2019","unstructured":"Ysselstein, D., Nguyen, M., Young, T. J., Severino, A., Schwake, M., Merchant, K., and Krainc, D. (2019) LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients, Nat. Commun., 10, 5570, \nhttps:\/\/doi.org\/10.1038\/s41467-019-13413-w.","journal-title":"Nat. Commun."},{"key":"2802_CR17","doi-asserted-by":"publisher","DOI":"10.25557\/2073-7998.2022.12.26-29","volume":"21","author":"T. S. Usenko","year":"2022","unstructured":"Usenko, T. S., Basharova, K. S., Bezrukova, A. I., Nikolaev, M. A., Miliukhina, I. V., Baydakova, G. V., Zakharova, E. Y., and Pchelina, S. N. (2022) Selective inhibition of LRRK2 activity as an approach to the treatment of Parkinson's disease [in Russian], Med. Genet., 21, 12, \nhttps:\/\/doi.org\/10.25557\/2073-7998.2022.12.26-29.","journal-title":"Med. Genet."},{"key":"2802_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00354-3","volume":"8","author":"M. Kedariti","year":"2022","unstructured":"Kedariti, M., Frattini, E., Baden, P., Cogo, S., Civiero, L., Ziviani, E., Zilio, G., Bertoli, F., Aureli, M., Kaganovich, A., Cookson, M. R., Stefanis, L., Surface, M., Deleidi, M., di Fonzo, A., Alcalay, R. N., Rideout, H., Greggio, E., and Plotegher, N. (2022) LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson\u2019s disease, NPJ Parkinsons Dis., 8, 92, \nhttps:\/\/doi.org\/10.1038\/s41531-022-00354-3.","journal-title":"NPJ Parkinsons Dis."},{"key":"2802_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00442","volume":"14","author":"A. Sanyal","year":"2020","unstructured":"Sanyal, A., Novis, H. S., Gasser, E., Lin, S., and LaVoie, M.\u00a0J. (2020) LRRK2 kinase inhibition rescues deficits in lysosome function due to heterozygous GBA1 expression in human IPSC-derived neurons, Front. Neurosci., 14, 442, \nhttps:\/\/doi.org\/10.3389\/fnins.2020.00442.","journal-title":"Front. Neurosci."},{"key":"2802_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2023.04.30.538317","author":"A. Mamais","year":"2023","unstructured":"Mamais, A., Sanyal, A., Fajfer, A., Zykoski, C. G., Guldin, M., Riley-DiPaolo, A., Subrahmanian, N., Gibbs, W., Lin, S., and LaVoie, M.\u00a0J. (2023) The LRRK2 kinase substrates Rab8a and Rab10 contribute complementary but distinct disease-relevant phenotypes in human neurons, bioRxiv, \nhttps:\/\/doi.org\/10.1101\/2023.04.30.538317.","journal-title":"bioRxiv"},{"key":"2802_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.289.3.347","volume":"289","author":"G. Rao","year":"2023","unstructured":"Rao, G., Fisch, L., Srinivasan, S., D\u2019Amico, F., Okada, T., Eaton, C., and Robbins, C. (2023) Does this patient have Parkinson disease? JAMA, 289, 347-353, \nhttps:\/\/doi.org\/10.1001\/jama.289.3.347.","journal-title":"JAMA"},{"key":"2802_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1134\/S1990519X19020081","volume":"13","author":"M. A. Nikolaev","year":"2019","unstructured":"Nikolaev, M. A., Kopytova, A. E., Baidakova, G.\u00a0V., Emel\u2019yanov, A. K., Salogub, G. N., Senkevich, K. A., Usenko, T. S., Gorchakova, M.\u00a0V., Koval\u2019chuk, Yu.\u00a0P., Berkovich, O. A., Zakharova, E. Yu., and Pchelina, S. N. (2019) Human peripheral blood macrophages as a model for studying glucocerebrosidase dysfunction, Cell Tissue Biol., 13, 100-106, \nhttps:\/\/doi.org\/10.1134\/S1990519X19020081.","journal-title":"Cell Tissue Biol."},{"key":"2802_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.chembiol.2014.06.008","volume":"21","author":"Y. L. Tan","year":"2014","unstructured":"Tan, Y. L., Genereux, J. C., Pankow, S., Aerts, J. M., Yates, J.\u00a0R., and Kelly, J.\u00a0W. (2014) ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher\u2019s disease, Chem. Biol., 21, 967-976, \nhttps:\/\/doi.org\/10.1016\/j.chembiol.2014.06.008.","journal-title":"Chem. Biol."},{"key":"2802_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1021\/cb600187q","volume":"1","author":"A. R. Sawkar","year":"2006","unstructured":"Sawkar, A. R., Schmitz, M., Zimmer, K. P., Reczek, D., Edmunds, T., Balch, W.\u00a0E., and Kelly, J.\u00a0W. (2006) Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants, ACS Chem. Biol., 1, 235-251, \nhttps:\/\/doi.org\/10.1021\/cb600187q.","journal-title":"ACS Chem. Biol."},{"key":"2802_CR25","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1074\/jbc.M511110200","volume":"281","author":"B. Liou","year":"2006","unstructured":"Liou, B., Kazimierczuk, A., Zhang, M., Scott, C. R., Hegde, R.\u00a0S., and Grabowski, G.\u00a0A. (2006) Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations, J.\u00a0Biol. Chem., 281, 4242-4253, \nhttps:\/\/doi.org\/10.1074\/jbc.M511110200.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2802_CR26","doi-asserted-by":"publisher","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","volume":"286","author":"T. L. Yap","year":"2011","unstructured":"Yap, T. L., Gruschus, J. M., Velayati, A., Westbroek, W., Goldin, E., Moaven, N., Sidransky, E., and Lee, J.\u00a0C. (2011) \u03b1-Synuclein interacts with glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases, J.\u00a0Biol Chem., 286, 28080-28088, \nhttps:\/\/doi.org\/10.1074\/jbc.M111.237859.","journal-title":"J.\u00a0Biol Chem."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297924602739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297924602739","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297924602739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:19:27Z","timestamp":1773620367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297924602739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2802"],"URL":"https:\/\/doi.org\/10.1134\/s0006297924602739","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      All procedures involving human participants adhered to the ethical standards of the National Ethics Committee and the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards. Informed consent was obtained from all participants. The study was approved by the Ethics Committee of\u00a0the Pavlov First St.\u00a0Petersburg State Medical University (protocol no.\u00a0275; September\u00a04, 2023).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}